World Cancer Day 2021
Thursday 4 February is World Cancer Day 2021, a day to raise awareness and improve education of cancer - and encourage action to help save lives.
World Cancer Day 2021
Every week, around two children in the UK are diagnosed with neuroblastoma, a rare and aggressive childhood cancer.
Wear our bracelets, order a t-shirt or make a donation to show your support for children with neuroblastoma and their families.
What is World Cancer Day?
World Cancer Day, led by the Union for International Cancer Control (UICC) unites people across the globe in the fight against cancer.
This year’s theme is ‘I Am and I Will’ and taking positive actions to make a difference.
How will you show your support this World Cancer Day?
I will…
Help fund research
Donate today and help fund vital research into neuroblastoma.
Take part in an event
From virtual runs to cycling events, sign up today to help save young lives.
Wear a bracelet
Wear our unique bracelets or ropelets to show your support this World Cancer Day,
Raise money
Find lots of ideas, hints and tips to help you raise money for Neuroblastoma UK.
Wear a t-shirt
We’ve collaborated with established and emerging artists to create an exclusive range of t-shirts, especially for you.
100% of profits from the sale of these fantastic t-shirts will be donated to Neuroblastoma UK.
How your support helps
Thanks to you, Neuroblastoma UK has invested over £7 million to help scientists develop new, effective and kinder treatments for children with neuroblastoma.
We support clinical and near-clinical research and drug development that has the potential to lead to improved treatment protocols. We also support basic research that improves our understanding of how neuroblastomas develop which may lead to novel, more effective approaches to treatment.
Researchers from the University of Sheffield and St. Anna Children’s Cancer Research Institute have created a model designed to investigate the origins of neuroblastoma, a cancer primarily affecting infants and young children. The findings offer hope for the creation of tailored treatments which treat aggressive neuroblastomas and minimise the adverse effects experienced by patients from existing therapies.